Document is current

Article History

Received: 1 September 2023

Accepted: 2 October 2023

First Online: 16 October 2023

Declarations

:

: The study has been approved by the Ethics Committee of the Capital Region of Denmark (H-22042603) and the Knowledge Center for Data Reviews of the Capital Region of Denmark (P-2022–953), and participants provide oral and written informed consent to participate.

: Not applicable.

: SR. Hamm receives grants from the Research Council of Rigshospitalet related to this study. SDN has received unrestricted research grants from the Novo Nordisk Foundation, Lundbeck Foundation, the Independent Research Fund Denmark, and reports advisory board activity for Gilead Sciences and GlaxoSmithKline/ViiV Healthcare, all unrelated to this manuscript. S.R. Hadrup is the cofounder of PokeAcell and coinventor of licensed patents related to T cell detection, but unrelated to this study. H. Birn has participated in advisory board activity for GlaxoSmithKline and has previously received research funding from GlaxoSmithKline unrelated to this study. SKS receives research funding from Lundbeck Foundation, the Danish Research Council, and the Danish Cancer Society for projects, all unrelated to this study. CSL has received honoraria from GlaxoSmithKline for lectures and participation in advisory boards. ZBH has received grants from Independent Research Fund, Lundbeck Foundation, Helen Rudes Foundation, and the Danish Cancer Society, all unrelated to this manuscript. ISJ, SSS, H. Bruunsgaard, AH, MASZ, CB, AVV, and NWP report no competing interests.